AAPL   316.57 (-0.68%)
FB   221.44 (-0.32%)
MSFT   166.50 (-0.36%)
GOOGL   1,482.25 (+0.18%)
AMZN   1,892.00 (+1.46%)
CGC   24.15 (-2.97%)
NVDA   247.94 (-0.54%)
BABA   222.26 (-2.27%)
MU   58.97 (+2.27%)
GE   11.66 (-1.27%)
TSLA   547.20 (+7.19%)
AMD   51.05 (+0.24%)
T   38.52 (+0.36%)
ACB   2.01 (-5.63%)
F   9.21 (+0.55%)
NFLX   338.11 (-0.46%)
PRI   126.41 (-1.57%)
BAC   34.26 (-1.30%)
DIS   143.56 (-0.53%)
GILD   62.63 (-0.56%)
AAPL   316.57 (-0.68%)
FB   221.44 (-0.32%)
MSFT   166.50 (-0.36%)
GOOGL   1,482.25 (+0.18%)
AMZN   1,892.00 (+1.46%)
CGC   24.15 (-2.97%)
NVDA   247.94 (-0.54%)
BABA   222.26 (-2.27%)
MU   58.97 (+2.27%)
GE   11.66 (-1.27%)
TSLA   547.20 (+7.19%)
AMD   51.05 (+0.24%)
T   38.52 (+0.36%)
ACB   2.01 (-5.63%)
F   9.21 (+0.55%)
NFLX   338.11 (-0.46%)
PRI   126.41 (-1.57%)
BAC   34.26 (-1.30%)
DIS   143.56 (-0.53%)
GILD   62.63 (-0.56%)
AAPL   316.57 (-0.68%)
FB   221.44 (-0.32%)
MSFT   166.50 (-0.36%)
GOOGL   1,482.25 (+0.18%)
AMZN   1,892.00 (+1.46%)
CGC   24.15 (-2.97%)
NVDA   247.94 (-0.54%)
BABA   222.26 (-2.27%)
MU   58.97 (+2.27%)
GE   11.66 (-1.27%)
TSLA   547.20 (+7.19%)
AMD   51.05 (+0.24%)
T   38.52 (+0.36%)
ACB   2.01 (-5.63%)
F   9.21 (+0.55%)
NFLX   338.11 (-0.46%)
PRI   126.41 (-1.57%)
BAC   34.26 (-1.30%)
DIS   143.56 (-0.53%)
GILD   62.63 (-0.56%)
AAPL   316.57 (-0.68%)
FB   221.44 (-0.32%)
MSFT   166.50 (-0.36%)
GOOGL   1,482.25 (+0.18%)
AMZN   1,892.00 (+1.46%)
CGC   24.15 (-2.97%)
NVDA   247.94 (-0.54%)
BABA   222.26 (-2.27%)
MU   58.97 (+2.27%)
GE   11.66 (-1.27%)
TSLA   547.20 (+7.19%)
AMD   51.05 (+0.24%)
T   38.52 (+0.36%)
ACB   2.01 (-5.63%)
F   9.21 (+0.55%)
NFLX   338.11 (-0.46%)
PRI   126.41 (-1.57%)
BAC   34.26 (-1.30%)
DIS   143.56 (-0.53%)
GILD   62.63 (-0.56%)
Log in
(Ad)
If you're looking to potentially make 1,000% in gains, then you NEED this biotech stock. This company discovered a medical breakthrough that may end heart attacks FOREVER! Estimated annual sales are $60 billion. The FDA has all but said it's going to approve the drug. Once that happens, the stock price could double overnight. But you must be onboard BEFORE FDA approval.

NYSE:APTV - Aptiv Stock Price, Forecast & News

$91.00
-0.53 (-0.58 %)
(As of 01/21/2020 04:00 PM ET)
Today's Range
$90.47
Now: $91.00
$91.91
50-Day Range
$87.89
MA: $93.48
$97.91
52-Week Range
$63.36
Now: $91.00
$99.04
Volume1.47 million shs
Average Volume1.69 million shs
Market Capitalization$23.23 billion
P/E Ratio23.39
Dividend Yield0.96%
Beta2.01
Aptiv PLC, together with its subsidiaries, designs and manufacturers vehicle components, and provides electrical, electronic, and safety technology solutions to the automotive and commercial vehicle markets worldwide. It operates through two segment, Signal and Power Solutions, and Advanced Safety and User Experience. The Signal and Power Solutions segment designs, manufactures, and assembles vehicle's electrical architecture, including engineered component products, connectors, wiring assemblies and harnesses, cable management, electrical centers, and hybrid high voltage and safety distribution systems. Read More…

Industry, Sector and Symbol

Industry Motor vehicle parts & accessories
Sub-IndustryAuto Parts & Equipment
SectorBusiness Services
CUSIPG2782310
Phone353-1259-7013

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$14.44 billion
Cash Flow$7.95 per share
Book Value$14.11 per share

Profitability

Net Income$1.07 billion

Miscellaneous

Employees143,000
Market Cap$23.23 billion
Next Earnings Date1/30/2020 (Confirmed)
OptionableOptionable

Receive APTV News and Ratings via Email

Sign-up to receive the latest news and ratings for APTV and its competitors with MarketBeat's FREE daily newsletter.


(Ad)

If you're looking to potentially make 1,000% in gains, then you NEED this biotech stock. This company discovered a medical breakthrough that may end heart attacks FOREVER! Estimated annual sales are $60 billion. The FDA has all but said it's going to approve the drug. Once that happens, the stock price could double overnight. But you must be onboard BEFORE FDA approval.

Aptiv (NYSE:APTV) Frequently Asked Questions

What is Aptiv's stock symbol?

Aptiv trades on the New York Stock Exchange (NYSE) under the ticker symbol "APTV."

How often does Aptiv pay dividends? What is the dividend yield for Aptiv?

Aptiv announced a quarterly dividend on Thursday, October 24th. Investors of record on Wednesday, November 6th will be paid a dividend of $0.22 per share on Wednesday, November 20th. This represents a $0.88 dividend on an annualized basis and a yield of 0.97%. The ex-dividend date of this dividend is Tuesday, November 5th. View Aptiv's Dividend History.

How were Aptiv's earnings last quarter?

Aptiv PLC (NYSE:APTV) issued its earnings results on Wednesday, October, 30th. The auto parts company reported $1.27 EPS for the quarter, hitting the Thomson Reuters' consensus estimate of $1.27. The auto parts company earned $3.56 billion during the quarter, compared to analyst estimates of $3.61 billion. Aptiv had a net margin of 6.99% and a return on equity of 34.88%. The business's quarterly revenue was up 2.1% on a year-over-year basis. During the same period last year, the firm posted $1.24 earnings per share. View Aptiv's Earnings History.

When is Aptiv's next earnings date?

Aptiv is scheduled to release their next quarterly earnings announcement on Thursday, January 30th 2020. View Earnings Estimates for Aptiv.

How can I listen to Aptiv's earnings call?

Aptiv will be holding an earnings conference call on Thursday, January 30th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

What guidance has Aptiv issued on next quarter's earnings?

Aptiv updated its FY19 earnings guidance on Wednesday, October, 30th. The company provided earnings per share (EPS) guidance of $4.62-4.68 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $5.06. The company issued revenue guidance of $14.255-14.355 billion, compared to the consensus revenue estimate of $14.58 billion.

What price target have analysts set for APTV?

23 equities research analysts have issued 1-year target prices for Aptiv's stock. Their forecasts range from $62.00 to $114.00. On average, they expect Aptiv's stock price to reach $96.14 in the next year. This suggests a possible upside of 5.7% from the stock's current price. View Analyst Price Targets for Aptiv.

What is the consensus analysts' recommendation for Aptiv?

23 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aptiv in the last year. There are currently 1 sell rating, 4 hold ratings, 16 buy ratings and 2 strong buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Aptiv.

Has Aptiv been receiving favorable news coverage?

News stories about APTV stock have trended somewhat positive on Tuesday, according to InfoTrie Sentiment Analysis. InfoTrie identifies positive and negative press coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Aptiv earned a news impact score of 2.0 on InfoTrie's scale. They also assigned media coverage about the auto parts company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the near future. View News Stories for Aptiv.

Who are some of Aptiv's key competitors?

What other stocks do shareholders of Aptiv own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Aptiv investors own include NVIDIA (NVDA), Paypal (PYPL), Verizon Communications (VZ), Walt Disney (DIS), Alibaba Group (BABA), AT&T (T), Gilead Sciences (GILD), Fitbit (FIT), Johnson & Johnson (JNJ) and Applied Materials (AMAT).

Who are Aptiv's key executives?

Aptiv's management team includes the folowing people:
  • Mr. Kevin P. Clark, Pres, CEO & Director (Age 57)
  • Mr. Joseph R. Massaro, Sr. VP & CFO (Age 49)
  • Mr. David M. Sherbin, Sr. VP, Gen. Counsel, Chief Compliance Officer & Sec. (Age 60)
  • Mr. David Paja, Sr. VP & Pres of Advanced Safety and User Experience (Age 49)
  • Mr. William H. Guggina, VP of Global Operations

Who are Aptiv's major shareholders?

Aptiv's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Calamos Advisors LLC (0.19%), Wedge Capital Management L L P NC (0.06%), Zurcher Kantonalbank Zurich Cantonalbank (0.03%), State of Alaska Department of Revenue (0.02%), Stralem & Co. Inc. (0.02%) and Legacy Private Trust Co. (0.02%). Company insiders that own Aptiv stock include Allan J Brazier, David M Sherbin, David Paja, Frank J Dellaquila, Joseph R Massaro, Kevin P Clark, Majdi Abulaban, Mark P Frissora, Susan M Suver and Vos Glen W De. View Institutional Ownership Trends for Aptiv.

Which major investors are selling Aptiv stock?

APTV stock was sold by a variety of institutional investors in the last quarter, including Sciencast Management LP, Stralem & Co. Inc., First Hawaiian Bank, Nisa Investment Advisors LLC, Wedge Capital Management L L P NC, Altfest L J & Co. Inc., Biltmore Wealth Management LLC and Gilman Hill Asset Management LLC. Company insiders that have sold Aptiv company stock in the last year include Allan J Brazier, David M Sherbin, Joseph R Massaro, Majdi Abulaban and Vos Glen W De. View Insider Buying and Selling for Aptiv.

Which major investors are buying Aptiv stock?

APTV stock was bought by a variety of institutional investors in the last quarter, including Calamos Advisors LLC, State of Alaska Department of Revenue, West Oak Capital LLC, BKD Wealth Advisors LLC, Calamos Wealth Management LLC, Legacy Private Trust Co., Brasada Capital Management LP and Advisors Preferred LLC. Company insiders that have bought Aptiv stock in the last two years include Frank J Dellaquila and Kevin P Clark. View Insider Buying and Selling for Aptiv.

How do I buy shares of Aptiv?

Shares of APTV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Aptiv's stock price today?

One share of APTV stock can currently be purchased for approximately $91.00.

How big of a company is Aptiv?

Aptiv has a market capitalization of $23.23 billion and generates $14.44 billion in revenue each year. The auto parts company earns $1.07 billion in net income (profit) each year or $5.26 on an earnings per share basis. Aptiv employs 143,000 workers across the globe.View Additional Information About Aptiv.

What is Aptiv's official website?

The official website for Aptiv is http://www.aptiv.com/.

How can I contact Aptiv?

Aptiv's mailing address is 5 HANOVER QUAY GRAND CANAL DOCK, DUBLIN L2, D02. The auto parts company can be reached via phone at 353-1259-7013 or via email at [email protected]


MarketBeat Community Rating for Aptiv (NYSE APTV)

Community Ranking:  3.2 out of 5 (star star star)
Outperform Votes:  960 (Vote Outperform)
Underperform Votes:  545 (Vote Underperform)
Total Votes:  1,505
MarketBeat's community ratings are surveys of what our community members think about Aptiv and other stocks. Vote "Outperform" if you believe APTV will outperform the S&P 500 over the long term. Vote "Underperform" if you believe APTV will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/21/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel